wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33840177-31252AC5-6E0D-4258-B2E0-57F8760FB2D5
Q33840177-31252AC5-6E0D-4258-B2E0-57F8760FB2D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33840177-31252AC5-6E0D-4258-B2E0-57F8760FB2D5
Well-differentiated neuroendocrine tumors: a review covering basic principles to loco-regional and targeted therapies
P2860
Q33840177-31252AC5-6E0D-4258-B2E0-57F8760FB2D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33840177-31252AC5-6E0D-4258-B2E0-57F8760FB2D5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0989a50c9f14ea92728bc7c625ab63355922ad93
P2860
Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors.